IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.60−7.13 (-2.69%)
Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –
Iqvia r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2015 it was $3.34M, down 42.4% from the year before. The highest annual figure on record is $10.43M in fiscal 2012.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $3.34M | -42.4% |
| FY2014 | Dec 31, 2014 | $5.79M | +16.9% |
| FY2013 | Dec 31, 2013 | $4.96M | -52.5% |
| FY2012 | Dec 31, 2012 | $10.43M | +4.4% |
| FY2011 | Dec 31, 2011 | $9.99M | – |
See a number that looks wrong?